The Role of Zero-Order Ultrasensitivity Amplification in the Regulation of the Glycogen Phosphorylase A — Phosphorylase B Cycle

  • R. D. Edstrom
  • J. S. Bishop
  • M. H. Meinke
Conference paper
Part of the NATO ASI Series book series (NSSA, volume 135)


Biological signaling systems generally contain amplification steps to offset attenuations of the signal. Diminution of signal may be caused by dilution of messenger molecules, desensitization of receptors and by the activities of specific antagonistic processes. Two general classifications of biochemical amplification have been described by Koshland et al. (1). Magnitude amplification depends on the ability of a single enzyme molecule to catalyze the conversion of many molecules of substrate. Several steps of magnitude amplification may be linked in a cascade such as found in blood clotting or hormonally induced glycogenolysis. Sensitivity amplification is a measure of the fractional change in response compared to the fractional change in signal. In the case of sensitivity amplification, the signal may be a small change in a relatively large concentration of stimulatory species with the response being a relatively larger change in a pre-existing level of output molecules. For example, a 10% increase in the concentration of signal molecules causing a 50% increase in the concentration of responding species yields a sensitivity amplification factor of 5. Sensitivity amplification is known to arise in three circumstances: Positive cooperativity, multiple inputs of a single effector and zero-order ultrasensitivity. The zero-order effect may occur in regulatory systems utilizing cyclic activation-deactivation through covalent modification of an enzyme protein. The regulated enzyme must be present at a concentration higher than the Michaelis constants of either or both of the two converter enzymes.


Mole Fraction Glycogen Phosphorylase Fractional Change Response Coefficient Phosphorylase Kinase 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Koshland, D. E., Jr., Goldbeter A. and Stock, J. B., Amplification and adaptation in regulatory and sensory systems, Science, 217:220 (1982).PubMedCrossRefGoogle Scholar
  2. 2.
    Fischer, E. H., Heilmeyer, L. M. G., Jr., and Haschke, R. H., Phosphorylase and the control of glycogen degradation. Gurr. Top. Cell. Regul, 4:211 (1971).Google Scholar
  3. 3.
    LaPorte D. C. and Koshland, D. E. Jr., Phosphorylation of isocitrate dehydrogenase as a demonstration of enhanced sensitivity in covalent regulation. Nature, 305:286 (1983).CrossRefGoogle Scholar
  4. 4.
    Meinke, M. H., Bishop, J. S. and Edstrom, R. D., Zero-order ultrasensitivity in the regulation of glycogen phosphorylase, Proc. Nat. Acad. Sci USA, 83:2865 (1986).PubMedCrossRefGoogle Scholar
  5. 5.
    Krebs, E. G., Love, D. S., Bratvold, G. E., Trayser, K. A., Meyer, W. L. and Fischer, E. H., Purification and properties of rabbit skeletal muscle phosphorylase b kinase, Biochemistry, 3:1022 (1964).PubMedCrossRefGoogle Scholar
  6. 6.
    Ingebritsen, T. S. and Cohen, P., Protein phosphatases: Properties and role in cellular regulation, Science, 221:331 (1983).PubMedCrossRefGoogle Scholar

Copyright information

© Plenum Press, New York 1987

Authors and Affiliations

  • R. D. Edstrom
    • 1
  • J. S. Bishop
    • 1
  • M. H. Meinke
    • 1
  1. 1.Departments of Biochemistry and MedicineUniversity of MinnesotaMinneapolisUSA

Personalised recommendations